Malaga Cove Capital’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-3,213
Closed -$280K 176
2025
Q2
$280K Sell
3,213
-110
-3% -$8.62K 0.11% 151
2025
Q1
$227K Sell
3,323
-8
-0.2% -$653 0.1% 170
2024
Q4
$259K Sell
3,331
-644
-16% -$47.7K 0.1% 173
2024
Q3
$266K Buy
3,975
+100
+3% +$8.21K 0.11% 161
2024
Q2
$439K Sell
3,875
-366
-9% -$46.3K 0.18% 127
2024
Q1
$588K Sell
4,241
-166
-4% -$20.9K 0.24% 111
2023
Q4
$547K Buy
4,407
+51
+1% +$5.21K 0.23% 109
2023
Q3
$406K Buy
4,356
+2,731
+168% +$308K 0.19% 122
2023
Q2
$209K Buy
+1,625
New +$197K 0.1% 146

Other funds holding DXCM

Malaga Cove Capital's DXCM Position: Q3 2025 in Review

Malaga Cove Capital sold out of DexCom (DXCM) in Q3 2025, closing a stake of 3,213 shares — an estimated $280K sold.

Malaga Cove Capital first reported a position in DXCM in Q2 2023 and held it in 9 quarters. The position peaked at $588K in Q1 2024. 910 funds tracked by Wall St. Rank hold DXCM as of Q3 2025.

  • Malaga Cove Capital reported no remaining DexCom position as of Q3 2025 after selling out during the quarter.
  • Malaga Cove Capital sold 3,213 DexCom shares in Q3 2025, an estimated $280K.
  • Malaga Cove Capital first reported a position in DexCom in Q2 2023 and held it in 9 quarters.
  • Malaga Cove Capital's DexCom position peaked at $588K in Q1 2024.
  • 910 funds tracked by Wall St. Rank held DexCom as of Q3 2025.

Based on Malaga Cove Capital's 13F filing for Q3 2025, filed 13 Nov 2025.